Knowledge is power-Rational design of cancer immunotherapy

Kristina De Paris

doi:10.1002/JLB.5CE0819-238R

Knowledge is power-Rational design of cancer immunotherapy

J Leukoc Biol. 2019 Nov;106(5):1003-1006. doi: 10.1002/JLB.5CE0819-238R. Epub 2019 Sep 26.

Author

Kristina De Paris¹

Affiliation

¹ Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA.

PMID: 31556463
DOI: 10.1002/JLB.5CE0819-238R

Abstract

Discussion on how our increasing knowledge on tumor immunity and host defense mechanisms has drastically changed our ability to improve cancer outcomes through the rational design of immunotherapies.

Publication types

Editorial
Comment

MeSH terms

CD8-Positive T-Lymphocytes
Humans
Immunologic Memory
Immunotherapy
Neoplasms*
Receptors, Interleukin-7
T-Lymphocytes*

Substances

Receptors, Interleukin-7
interleukin-7 receptor, alpha chain